Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

Roche will continue a careful approach to high-priced deals, putting science at the center of its business development ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00.

Roche Pharma India has appointed Rajwinder (Rajji) Mehdwan as country general manager, effective 1st April, 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The primary driver behind last 12 months revenue was the Pharmaceuticals - Roche Pharmaceuticals segment contributing a total revenue of CHF46.3b (74% of total revenue). The largest operating ...

Earnings per share (EPS) missed analyst estimates by 38%. The primary driver behind last 12 months revenue was the Pharmaceuticals - Roche Pharmaceuticals segment contributing a total revenue of CHF46 ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

The pharmaceutical giant said for 2025 it anticipates sales growth in the mid-single-digit range at constant exchange rates, ...